These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10649220)

  • 1. Myocyte contractile dysfunction with hypertrophy and failure: relevance to cardiac surgery.
    Walker CA; Crawford FA; Spinale FG
    J Thorac Cardiovasc Surg; 2000 Feb; 119(2):388-400. PubMed ID: 10649220
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrophysiological remodeling in hypertrophy and heart failure.
    Tomaselli GF; Marbán E
    Cardiovasc Res; 1999 May; 42(2):270-83. PubMed ID: 10533566
    [No Abstract]   [Full Text] [Related]  

  • 3. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
    Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
    Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical problems in cardiac hypertrophy and chronic insufficiency].
    Swynghedauw B
    Nouv Presse Med; 1979 Oct; 8(38):3021-4. PubMed ID: 160541
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of increased Ca++ influx as a possible additional adaptive mechanism in experimental left ventricular hypertrophy (exp LVH).
    Arsenescu G; Sabău M; Roşca G; Roşca S; Avrigeanu V
    Physiologie; 1978; 15(3):157-60. PubMed ID: 152441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
    Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
    Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological aspects of myocardial hypertrophy.
    Dhalla NS; Heyliger CE; Beamish RE; Innes IR
    Can J Cardiol; 1987 May; 3(4):183-96. PubMed ID: 3036324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
    Doenst T; Pytel G; Schrepper A; Amorim P; Färber G; Shingu Y; Mohr FW; Schwarzer M
    Cardiovasc Res; 2010 Jun; 86(3):461-70. PubMed ID: 20035032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart spotting.
    el Azzouzi H; De Windt LJ
    Basic Res Cardiol; 2008 May; 103(3):228-31. PubMed ID: 18274799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered contractile function in heart failure.
    de Tombe PP
    Cardiovasc Res; 1998 Feb; 37(2):367-80. PubMed ID: 9614494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular basis of cardiac contractile failure.
    Dhalla NS; Das PK; Sharma GP
    J Mol Cell Cardiol; 1978 Apr; 10(4):363-85. PubMed ID: 205659
    [No Abstract]   [Full Text] [Related]  

  • 12. The structure and function of the cardiac myocyte: a review of fundamental concepts.
    Walker CA; Spinale FG
    J Thorac Cardiovasc Surg; 1999 Aug; 118(2):375-82. PubMed ID: 10425017
    [No Abstract]   [Full Text] [Related]  

  • 13. Co-expression of skeletal and cardiac troponin T decreases mouse cardiac function.
    Huang QQ; Feng HZ; Liu J; Du J; Stull LB; Moravec CS; Huang X; Jin JP
    Am J Physiol Cell Physiol; 2008 Jan; 294(1):C213-22. PubMed ID: 17959729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic therapy in cardiac surgery--"Optimizing the engine's fuel supply and more...".
    Doenst T; Amorim PA
    Scand Cardiovasc J; 2010 Feb; 44(1):4-8. PubMed ID: 20141343
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment.
    Sabbah HN; Sharov VG; Gupta RC; Mishra S; Rastogi S; Undrovinas AI; Chaudhry PA; Todor A; Mishima T; Tanhehco EJ; Suzuki G
    Circ Res; 2003 Nov; 93(11):1095-101. PubMed ID: 14563716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The regulatory role of membrane protein conformation in trans-sarcolemmal transport of cations during the contraction-relaxation cycle of the heart].
    Vrbjar N; Ziegelhöffer A; Dŭrba A; Styk J
    Bratisl Lek Listy; 1986 Mar; 85(3):282-8. PubMed ID: 2420421
    [No Abstract]   [Full Text] [Related]  

  • 17. Alteration in calcium metabolism in cardiac hypertrophy and failure caused by bacterial infection.
    Tomlinson CW; Dhalla NS
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():191-8. PubMed ID: 145639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of myocardial contractile state and the intracellular calcium transients during transitions to heart failure: studies in Dahl rat heart failure model.
    Kihara Y; Inoko M; Sasayama S
    J Card Fail; 1996 Dec; 2(4 Suppl):S113-20. PubMed ID: 8951568
    [No Abstract]   [Full Text] [Related]  

  • 19. [The significance of myocardial hypertrophy in heart failure].
    Holtz J
    Z Kardiol; 1992; 81 Suppl 4():41-8. PubMed ID: 1290305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Abnormalities of ion movements in cardiac hypertrophy and failure].
    Coraboeuf E
    Therapie; 1992; 47(3):171-9. PubMed ID: 1295117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.